The neuropeptide Y Y5 receptor mediates the blockade of "photic-like" NMDA-induced phase shifts in the golden hamster

Journal of Neuroscience

Volumn 21, Issue 14, 2001, Pages 5367-5373

  Yannielli, P C ^a   Harrington, M E ^a  

^a SMITH COLLEGE   (United States)

Author keywords

Circadian rhythms; Entrainment; NMDA; NPY; Photic nonphotic interaction; Single unit activity; Suprachiasmatic nuclei; Syrian hamster

Indexed keywords

N METHYL DEXTRO ASPARTIC ACID; NALPHA (DIPHENYLACETYL) N (4 HYDROXYBENZYL) DEXTRO ARGININAMIDE; NEUROPEPTIDE Y RECEPTOR AGONIST; NEUROPEPTIDE Y RECEPTOR ANTAGONIST; NEUROPEPTIDE Y5 RECEPTOR; RWJ 57926; SEROTONIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CIRCADIAN RHYTHM; CONTROLLED STUDY; CORTICAL SYNCHRONIZATION; DOSE RESPONSE; HAMSTER; INFORMATION PROCESSING; MALE; NERVE CONDUCTION; NEUROTRANSMISSION; NONHUMAN; PHOTOSTIMULATION; PRIORITY JOURNAL; RECEPTOR BLOCKING; SUPRACHIASMATIC NUCLEUS;

EID: 0035879177     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.21-14-05367.2001     Document Type: Article

References (54)

1. Inhibition of light- or glutamate-induced mPer1 expression represses the phase shifts into the mouse circadian locomotor and suprachiasmatic firing rhythms
2. Enhanced photic phase shifting after treatment with antiserum to neuropeptide Y
3. Neuropeptide Y and behaviorally induced phase shifts
4. Neuropeptide Y and glutamate block each other's phase shifts in the suprachiasmatic nucleus in vitro
5. The first selective agonist at the neuropeptide Y Y5-Receptor increases food intake in rats
6. NMDA as well as non-NMDA receptor antagonists can prevent the phase-shifting effects of light on the circadian system of the golden hamster
7. Responses to neuropeptide Y in adult hamster suprachiasmatic nucleus neurones in vitro
8. Light-sampling behavior in photoentrainment of a rodent circadian rhythm
9. Resetting the biological clock: Mediation of nocturnal circadian shifts by glutamate and nitric oxide
10. Molecular bases for circadian clocks
11. The role of glutamate in the photic regulation of the suprachiasmatic nucleus
12. The glutamate induced phase shift in the SCN slice: A two pulse study
13. [Leu31, Pro34] neuropeptide Y: A specific Y1 receptor agonist
14. Effect of neuropeptide Y on PER1 gene expression in the hamster SCN in vitro
15. A receptor subtype involved in neuropeptide-Y-induced food intake
16. SCN electrophysiology in vitro: Rhythmic activity and endogenous clock properties
17. Neuropeptide phase shifts the circadian clock in vitro via a Y2 receptor
18. Neuropeptide Y 3-36 is an endogenous ligand selective for Y2 receptors
19. Phase shifting of circadian rhythms and depression of neuronal activity in the rat suprachiasmatic nucleus by neuropeptide Y: Mediation by different receptor subtypes
20. Role of membrane conductances and protein synthesis in subjective day phase advances of the hamster circadian clock by neuropeptide Y
21. The ventral lateral geniculate nucleus and the intergeniculate leaflet: Interrelated structures in the visual and circadian systems
22. NPY opposes PACAP phase shifts via receptors different from those involved in NPY phase shifts
23. Identification of a novel hypothalamic neuropeptide Y receptor associated with feeding behavior
24. 2 -like receptors
25. Molecular characterization of the ligand-receptor interaction of neuropeptide Y
26. Intergeniculate leaflet lesions and behaviorally-induced shifts of circadian rhythms
27. Distribution of neuropeptide Y receptor expression in the rat suprachiasmatic nucleus
28. Single unit response of neurons within the hamster suprachiasmatic nucleus to neuropeptide Y in the hypothalamic slice preparation
29. Molecular dissection of two distinct actions of melatonin on the suprachiasmatic circadian clock
30. Role of the Y5 neuropeptide Y receptor in limbic seizures
31. The effect of central infusions of NPY on the expression of clock genes in the suprachiasmatic nuclei of the mouse
32. Rapid down-regulation of mammalian period genes during behavioral resetting of the circadian clock
33. Light exposure prior to slice preparation can induce increased PER1 and PER2 levels measured in vitro
34. N-Acylated α-(3-pyridylmethyl)-β-aminotetralin antagonists of the human neuropeptide Y Y5 receptor
35. The effects of glutamate on membrane potential and discharge rate of suprachiasmatic neurons
36. Activation of NMDA receptors in the suprachiasmatic nucleus produces light-like phase shifts on the circadian clock in vivo
37. Serotonergic innervation of the hypothalamic suprachiasmatic nucleus and photic regulation of circadian rhythms
38. Activity rhythms and photoperiodism of Syrian hamsters in a simulated burrow system
39. Neuropeptide Y blocks serotonergic phase shifts of the suprachiasmatic circadian clock in vitro
40. Serotonin modulates glutamate responses in isolated suprachiasmatic nucleus neurons
41. Behavioral inhibition of circadian responses to light
42. Serotonin modulates photic responses in the hamster suprachiasmatic nuclei
43. Possible involvement of neuropeptide Y in the seasonal control of hydroxyindole-O-methyltransferase activity in the pineal gland of the European hamster (Cricetus cricetus)
44. The first highly potent and selective non-peptide neuropeptide Y Y1receptor antagonist: BIBP3226
45. N-Methyl-D-aspartate induces phase shifts in circadian rhythm of neuronal activity of rat SCN in vitro
46. Glutamate shifts the phase of the circadian neuronal firing rhythm in the rat suprachiasmatic nucleus in vitro
47. Differential cAMP gating of glutamatergic signaling regulates long-term changes in the suprachiasmatic circadian clock
48. Neuropeptide Y-mediated long term depression of exitatory activity in suprachiasmatic nucleus neurons
49. Neuropeptide Y blocks light-induced phase advances but not delays of the circadian activity rhythm in hamsters
50. Local administration of serotonin agonists blocks light-induced phase advances of the circadian activity rhythm in the hamster
51. Cloning and expression of a novel neuropeptide Y receptor
52. Subtype selectivity and antagonistic profile of the nonpeptide Y1 receptor antagonist BIBP 3226
53. Neuropeptide Y applied in vitro can block the phase shifts induced by light in vivo
54. α-substituted N-(sulfonamido)alkyl-β-aminotetralins: Potent and selective neuropeptide Y Y5 receptor antagonists